Daiken Biomedical Co., Ltd. (TPE:7780)
18.00
-0.35 (-1.91%)
At close: May 14, 2026
Daiken Biomedical Revenue
Daiken Biomedical had revenue of 463.84M TWD in the quarter ending March 31, 2026, with 38.55% growth. This brings the company's revenue in the last twelve months to 2.02B, up 39.00% year-over-year. In the year 2025, Daiken Biomedical had annual revenue of 1.90B with 39.10% growth.
Revenue (ttm)
2.02B
Revenue Growth
+39.00%
P/S Ratio
7.16
Revenue / Employee
n/a
Employees
20
Market Cap
14.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.90B | 532.70M | 39.10% |
| Dec 31, 2024 | 1.36B | 171.97M | 14.45% |
| Dec 31, 2023 | 1.19B | 305.45M | 34.52% |
| Dec 31, 2022 | 884.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition